Real-time breath analysis for early detection of invasive fungal infections in high-risk patients (REDEFINE)
Descrizione riassuntiva dello studio
Invasive pulmonary fungal infections (IPF) are a complication of intensive chemotherapy used for patients with acute leukemia. This complication occurs in about 10% of patients. IPF leads to significant suffering and long-term damage as fungal growth destroys the lungs, often requiring surgical removal of the affected part for definitive healing. The diagnosis of IPF is challenging as a biopsy is usually necessary, which can also lead to complications. The available non-invasive tests are unsuitable for early detection of IPF, as they typically yield positive results only at advanced stages of the disease (if at all). Early detection of IPF would allow for early intensive antifungal therapy to curb the spread of the fungus. Therefore, the development of a non-invasive test for IPF is urgently needed. Real-time breath analysis is a harmless non-invasive method that has shown promising results as a candidate for early detection of IPF in preliminary studies. We therefore propose a larger study with patients at very high risk for IPF to test whether real-time breath analysis can indeed detect IPF early. Both patients at very high risk for IPF and the machine for breath analysis are available at our hospital. This study will answer the question of whether real-time breath analysis can detect IPF early to significantly improve diagnostics for IPF. The results will also serve as a basis for further studies that can test the effectiveness and safety of early intensive antifungal therapy for patients with early-stage IPF, so that the progression of lung destruction by the fungus can be prevented early.
(BASEC)
Intervento studiato
Real-time breath analysis
(BASEC)
Malattie studiate
Invasive pulmonary fungal infections (e.g., aspergillosis, mucormycosis) in patients with neutropenia
(BASEC)
Adult patients with acute leukemia Planned chemotherapy with hospitalization at the University Hospital Zurich for two weeks or more Neutropenia (<500/µl) at inclusion or expected neutropenia for more than 7 days. (BASEC)
Criteri di esclusione
Inability to follow instructions for a breath analysis Anatomical abnormalities preventing the use of a mouthpiece (BASEC)
Luogo dello studio
Zurigo
(BASEC)
Sponsor
Jeremy Deuel, USZ
(BASEC)
Contatto per ulteriori informazioni sullo studio
Persona di contatto in Svizzera
Jeremy Deuel
+41 41 255 11 11
jeremy.deuel@clutterusz.chUniversitätsSpital Zürich Rämistrasse 100 8091 Zürich
(BASEC)
Informazioni scientifiche
non disponibile
Nome del comitato etico approvante (per studi multicentrici solo il comitato principale)
Commissione etica Zurigo
(BASEC)
Data di approvazione del comitato etico
14.06.2024
(BASEC)
ID di studio ICTRP
non disponibile
Titolo ufficiale (approvato dal comitato etico)
Real-time breath analysis for the detection of invasive fungal infections in neutropenic high-risk patients (REDEFINE) (BASEC)
Titolo accademico
non disponibile
Titolo pubblico
non disponibile
Malattie studiate
non disponibile
Intervento studiato
non disponibile
Tipo di studio
non disponibile
Disegno dello studio
non disponibile
Criteri di inclusione/esclusione
non disponibile
non disponibile
Endpoint primari e secondari
non disponibile
non disponibile
Data di registrazione
non disponibile
Inclusione del primo partecipante
non disponibile
Sponsor secondari
non disponibile
Contatti aggiuntivi
non disponibile
ID secondari
non disponibile
Risultati-Dati individuali dei partecipanti
non disponibile
Ulteriori informazioni sullo studio
non disponibile
Risultati dello studio
Riepilogo dei risultati
non disponibile
Link ai risultati nel registro primario
non disponibile